Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Indomethacin price increase 2022 2023 infographic?Indomethacin er coupon?Infographics archive indomethacin price increase?Aztreonam brand name?Varenicline tartrate cost?
See the DrugPatentWatch profile for Nexletol
Nexletol (bempedoic acid) is used to treat adults with high cholesterol, specifically to lower low-density lipoprotein cholesterol (LDL-C). It’s prescribed as an “add-on” therapy along with diet and other cholesterol-lowering medicines when LDL-C is not controlled enough with standard treatment.
It’s typically used for adults who need additional LDL-C lowering despite lifestyle changes and/or other lipid therapies (such as statins and other cholesterol medicines). It is commonly considered in people at higher cardiovascular risk because lowering LDL-C helps reduce cardiovascular events.
Nexletol is generally used in combination with other LDL-C–lowering treatments rather than as a standalone therapy. The point is to provide extra LDL-C reduction for patients who still have LDL-C above target levels.
Because Nexletol is an LDL-C–lowering medication, it’s used in the broader setting of: - Primary hypercholesterolemia (high cholesterol) - Mixed dyslipidemia (more than one lipid abnormality) when additional LDL-C reduction is needed to reach goals set by the treating clinician.
Some patients also hear about Nexlizet, which combines bempedoic acid with ezetimibe. That can change the regimen, but the core purpose—lowering LDL-C—remains.
Other Questions About Nexletol :